Krishna Institute of Medical Sciences (KIMS) — Corporate Action

📢 Key Event
KIMS gets in-principle approval for 77 lakh convertible warrants to promoters

🔄 What Changed
77,02,182 warrants approved for preferential allotment to promoters

KIMS announced in-principle approval from BSE and NSE to issue 77,02,182 fully convertible warrants to promoters at Rs 2 face value, submitted on 17 June 2026 under SEBI LODR Regulation 28. The approvals are subject to statutory clearances, compliance with SEBI ICDR norms, and internal control requirements before allotment.

📄 View Original Announcement (PDF)

📊 Stock Analysis — KIMS ✨ Ask AI About This

About Krishna Institute of Medical Sciences Limited (KIMS)

Healthcare · Healthcare Services · Listed on NSE

Market Cap: ₹30,476.58 Cr P/E: 80.3

View full KIMS stock details →

📡 Get AI alerts when KIMS files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track KIMS — Free

💡 Ask AI about this filing

"What is the conversion price and timeline for these warrants?" "How will this affect KIMS's shareholding structure and dilution?" "What are the expected dates for statutory approvals and listing application filing?"

Ask AI Free →

📊 More KIMS filings

See all KIMS filings →

🔥 Also filed on 7 August 2026

OLAELEC Ola Electric Mobility Limited Financial Results NCC NCC Limited Financial Results GRWRHITECH Garware Hi-Tech Films Limited Financial Results ARVSMART Arvind SmartSpaces Limited Financial Results BEML BEML Limited Financial Results RUSTOMJEE Keystone Realtors Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when KIMS files new disclosures

Track KIMS filings, board meetings, and corporate actions. Free email alerts at 5 PM.